GluBio Therapeutics Funding: $90M Raised, Series A (2022)
GluBio Therapeutics is based in San Diego, California. It has raised $90M in total funding. Latest round: Series A.
GluBio Therapeutics funding overview
GluBio Therapeutics is based in San Diego, California. GluBio Therapeutics has raised $90M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2022. The round record for GluBio Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Qiming Venture Partners, Lilly Asia Ventures, Kaitai Capital. 3 distinct backers are named across the disclosed rounds.
GluBio Therapeutics at a glance
Total raised
$90M
Latest round
Series A
Latest round date
July 2022
Headquarters
San Diego, California
Notable investors
Qiming Venture Partners, Lilly Asia Ventures, Kaitai Capital
Frequently asked about GluBio Therapeutics funding
How much has GluBio Therapeutics raised?
GluBio Therapeutics has raised $90M in total disclosed funding across the rounds on record.
Who has invested in GluBio Therapeutics?
Qiming Venture Partners, Lilly Asia Ventures, Kaitai Capital are named among the investors backing GluBio Therapeutics.
What was the latest GluBio Therapeutics funding round?
The most recent disclosed round is a Series A, announced in July 2022.
Where is GluBio Therapeutics based?
GluBio Therapeutics is based in San Diego, California.
When did GluBio Therapeutics last raise?
The last disclosed GluBio Therapeutics round closed in July 2022 at Series A.
Totals shown for GluBio Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.
